TrialThe Journal of infectious diseases2022

Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-Seronegative Children.

Coleen K Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.